BiotechTube
Home/Tavanta Therapeutics/Darren Brayton
DB

Darren Brayton

Vice President, Technical Operations

Tavanta Therapeutics

Therapeutic Areas

OncologyColorectal CancerUro-oncology

Tavanta Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Colorectal Program(s)Colorectal CancerPhase 2
Undisclosed Uro-oncology Program(s)Uro-oncology (e.g., bladder, kidney, prostate cancers)Phase 2

Leadership Team at Tavanta Therapeutics

LP
Lynne Powell
Chief Executive Officer
DA
Dr. Andreas Maetzel
Chief Medical Officer
DE
Dr. Elizabeth Manning Duus
Vice President, Clinical Development
View full Tavanta Therapeutics profile